BALANCE-ET, a research project involving the BIH, examines the quality of life of breast cancer survivors and investigates how relapses and long-term side effects can be better prevented. On February 4, State Secretary Matthias Hauer presented the funding approval during his visit to the National…
To ensure that people are not only treated when they are ill, but that diseases do not develop in the first place, medicine must systematically incorporate preventive measures. The BIH Biomedical Innovation Academy (BIA) and Charité – Universitätsmedizin Berlin are launching their Advanced Clinician…
BIH Professor Dr. Carsten Tschöpe received special recognition at the “HFA Winter Meeting on Translational Heart Failure Research” in Berlin. He delivered the prestigious Brutsaert Lecture to an international audience—an honor linked to a lifetime achievement award in translational cardiovascular…
The Berlin Institute of Health at Charité (BIH) is strengthening its research faculty in February with the appointments of Dr. Leif Si-Hun Ludwig and Dr. Daniel Ortmann. Ludwig has been awarded a prestigious Heisenberg professorship in stem cell dynamics and mitochondrial genomics, a position funded…
BIH professor Kirsten Kübler has been awarded the Claudia von Schilling Prize 2025, worth €10,000, for her publication on tamoxifen-associated uterine cancer.
The Neuroendocrine Tumor Research Foundation (NETRF) honoured 13 researchers for their work on the treatment of neuroendocrine cancers. Prof. Dr. Kübler receives funding for a research project on tumors of the hormone-producing islet cells of the pancreas.
A team led by former BIH professor Prof. Dr. Sarah Hedtrich focused on a form of fish scale disease known as autosomal recessive congenital ichthyosis (ARCI). This is a rare, hereditary skin disorder that disrupts the formation of the body's skin cornea. Those affected often have dry, reddened and…
Researchers at Charité – Universitätsmedizin Berlin and the BIH Center for Regenerative Therapies (BCRT) have gained new insights into immune responses to therapeutic mRNAs. Here, senior author and study lead Dr. Norman Drzeniek answers questions about the research findings.
Researchers at the Berlin Institute of Health (BIH) at Charité, in collaboration with the technology firm Cellbricks, have developed a 3D printer capable of producing biological bandages. These custom-fit wound dressings are designed to seal large-scale injuries and could offer a transformative…
Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers at the Berlin Institute of Health at Charité (BIH) have developed a method to evaluate multiple therapeutic approaches on patient-derived “tumoroids” – miniature tumors grown…
In the treatment of tumors such as malignant melanoma (black skin cancer), a therapy can be used in which the patients’ own immune cells are modified in the laboratory and then returned to them to fight the disease. However, selecting the immune cells suitable for this purpose has so far been a…
Oslo Cancer Cluster, in collaboration with the Berlin Center for Gene and Cell Therapies, has published a new whitepaper “Bridging the Gaps: Unlocking the Future of Advanced Therapies in Europe via Novel Alliances.” The whitepaper builds on a expert roundtable hosted at the Nordic Embassies in…
With a total of €13 million in funding, eleven new projects are being launched—including the EC-EDI, in which the BIH is participating. Berlin-based researchers combine modern technologies such as single-cell multiomics, spatial biology, and AI to detect and treat diseases at an early stage.
Prof. Dr. Petra Ritter, head of the Brain Simulation Group at BIH, and her team are part of the newly launched industry collaboration within the IHI BRIDGE consortium. They contribute their expertise as leaders of the EU Testing and Experimentation Facility (TEF-Health) to the project.
Claudia Langenberg, Professor of Computational Medicine at the BIH and Director of the Precision Healthcare University Research Institute (PHURI), has been awarded an ERC Consolidator Grant by the European Research Council.
Since the last certificate award ceremony at the International Clinician Scientist Symposium (June 2024), more than 60 program participants have completed their BIH Charité (Junior) (Digital) (Advanced) Clinician Scientist training. This means that the alumni community continues to grow – we are…
This year, the retreat took us and around 150 participants to the “Villa Elisabeth” in Berlin Mitte for an inspiring day. The aim of the one-day CSP retreat was to strengthen the interdisciplinary networking of the fellows. The (Junior) (Digital) Clinician Scientists helped design the program from…
Societally, the topic is rather taboo, and knowledge about treatment options is limited: Women going through menopause often suffer from symptoms such as hot flashes, irregular bleeding, sleep disturbances, and concentration problems. These typical complaints frequently affect the well-being, daily…
The Einstein Foundation Berlin honors the Australian psychologist Simine Vazire, the Brazilian Reproducibility Initiative, and the project Erring Rigorously with the Einstein Foundation Award for Promoting Quality in Research 2025. The latter project receives the Early Career Award for exploring how…
A total of five projects supervised by Charité BIH Innovation — the joint technology transfer of Charité and BIH — have successfully qualified for the GO-Bio initial program of the Federal Ministry of Research, Technology, and Space (BMFTR). While NEUROLITH will begin the two-year feasibility phase…
Whether it was stem cells, single-cell technologies, Wikipedia entries about female researchers, or the future of the academic publishing system, visitors had a lot to see at the Berlin Science Week this year. In two roundtable discussions, experts also addressed how biomedical innovation systems in…
The Berlin Institute of Health at Charité (BIH) successfully concluded its Digital Health Accelerator Demo Day in October 2025. The virtual event brought together clinicians, researchers, investors, and innovators in digital health to present solutions developed by those working closest to patients.…
The Coalition for Advancing Research Assessment (CoARA) is awarding the Berlin Institute of Health at Charité nearly €60,000 to advance the development of a transparent and fair infrastructure for evaluating research groups. To this end, BIH researchers are expanding the existing MERIT portal for…
On October 9, 2025, around 400 members of the Berlin Institute of Health at Charité (BIH) came together from across the different campuses for a day dedicated to exchange, collaboration, and networking. The symposium focused entirely on translation – it served as the guiding theme and unifying…
SPARK-BIH celebrated its 10th anniversary this fall with a three-day series of events at the historic Villa Elisabeth in Berlin. The occasion brought together more than 220 participants — including colleagues, founders, supporters, advisors, alumni, and current SPARK teams — to reflect on a decade…
The Berlin Institute of Health at Charité (BIH) is pleased to welcome Prof. Dr. Katy Börner as a new Visiting Fellow. The internationally renowned scientist has been working at the BIH since June 2025 for a period of three years as part of the “Visiting Fellow” program funded by the Charité…
Every organism’s genome contains mutations that often have unknown biological effects. In partnership with Stanford University (USA), researchers at Charité – Universitätsmedizin Berlin and the BIH have now discovered a way to predict the effects of numerous mutations in yeast. Key to this discovery…
The Berlin Institute of Health at Charité (BIH) bids farewell to Prof. Dr. Ulrich Dirnagl, honoring him as a central driving force for trustworthy and useful research upon his retirement. The internationally recognized stroke researcher and advocate of responsible science has shaped the biomedical…
Over 130 researchers and change-makers gathered from 22 to 24 September in Berlin for RRiA Unconference 2025, a three-day event driving transformation in research culture. With inspiring talks, hands-on projects, and vibrant networking, participants united to rethink and improve how science is done…
The Berlin Institute of Health at Charité (BIH) is strengthening its expertise in translational research with two new W2 professorships: Dr. Sven Geißler has been appointed Professor of “Biological Foundations of Musculoskeletal Regeneration,” and Dr. Daniel Ibrahim has been appointed Professor of…
